# Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia

> **NCT05157100** · PHASE4 · COMPLETED · sponsor: **The Orthopedic Foundation** · enrollment: 20 (actual)

## Conditions studied

- Cervical Dystonia

## Interventions

- **DRUG:** Ingrezza Pill

## Key facts

- **NCT ID:** NCT05157100
- **Lead sponsor:** The Orthopedic Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-19
- **Primary completion:** 2023-09-15
- **Final completion:** 2023-09-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05157100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05157100, "Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05157100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*